Trends in breast cancer by race and ethnicity

Ca-A Cancer Journal for Clinicians

Volumn 53, Issue 6, 2003, Pages 342-355

  Ghafoor, Asma ^a   Jemal, Ahmedin ^a   Ward, Elizabeth ^a   Cokkinides, Vilma ^a   Smith, Robert ^a   Thun, Michael ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BREAST CANCER; BREAST EXAMINATION; BREAST SURGERY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER STATISTICS; CANCER SURVIVAL; CAUCASIAN; CLINICAL EXAMINATION; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MOTIVATION; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES;

EID: 0346495955     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.53.6.342     Document Type: Article

References (41)

1. IARC, WHO. Breast cancer, in Stewart B, Kleihues P (eds). World Cancer Report. Lyon: IARC Press, 2003;188-19.
2. Armstrong B. Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer 1976;17:204-211.
3. King S, Schottenfeld D. The "epidemic" of breast cancer in the U. S. -Determining the factors. Oncology 1996;10:453-472.
4. Chu K, Tarone R, Kessler L, et al. Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88: 1571-1579.
5. Miller B, Feuer E, Hankey B. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;43:27-41.
6. Garfinkel L, Boring CC, Heath CW Jr. Changing trends. An overview of breast cancer incidence and mortality. Cancer 1994;74:222-227.
7. Smith R, Saslow D. Breast cancer, in Wingood GM, DiClemente RJ (eds). Handbook of Women's Sexual and Reproductive Health. New York: Kluwer Academics/Plenum Publishers, 2002; pp 345-365.
8. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public Use, Nov. 2002 Sub (1973-2000) < 18 Age Groups >, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
9. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003.
10. National Center for Health Statistics. Division of Vital Statistics, Centers for Disease Control. Available at: http://www.cdc.gov/nchs/nvss.htm, 2003.
11. US Census Bureau. Available at: http://www.census.gov.
12. National Center for Health Statistics. Health, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, 2002.
13. Wingo PA, Landis S, Parker S, et al. Using cancer registry and vital statistics to estimate the number of new cases cancer cases and deaths in the US for the upcoming year. J Registry Management 1998;25:43-9.
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Star Med 2000;19: 335-351.
15. SAS Institute. SAS/STAT User's Guide, version 6, vol. 1. Cary, NC: SAS Institute, 1989.
16. Surveillance Research Program, National Cancer Institute SEER*Stat software (available at www. seer. cancer. gov/seerstat), version 5.0.17.
17. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
18. Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Star Rep 2003;51: 1-94.
19. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-545.
20. Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 1992;84:1402-1410.
21. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289: 3243-3253.
22. Wong SL, Chao C, Edwards MJ, et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182: 330-334.
23. Centers for Disease Control and Prevention. The National Breast and Cervical Cancer Early Detection Program-Reducing Mortality Through Screening. Available at http://www.cdc.gov/cancer/nbccedp/about.htm, 2003.
24. Implementing recommendation for the early detection of breast and cervical cancer among low income women. MMWR 2000;49:37-50.
25. Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health 2000;90:130-134.
26. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 2002;94:471-473.
27. Ernster VL, BarclayJ, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275: 913-918.
28. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 2002;162:1985-1993.
29. National Cancer Institute. Breast Cancer (PDQ): Treatment. Health Professional Version. Available at http://cancer.gov/cancerinfo/pdq/treatment/breast/healthprofessional/, 2003.
30. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;352:930-942.
31. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised. trials. Lancet 1998; 351:1451-1467.
32. Mariotto A, Feuer EJ, Harlan LC, et al. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 2002;94:1626-1634.
33. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326:1097-1101.
34. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-726.
35. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 2000;89:561-573.
36. Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 2002;95:1759-1766.
37. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African Amican and white women in an equal-access health care system. Cancer 1998;82: 1310-1318.
38. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106-2113.
39. Guidance and Summary of Actions on the Breast and Cervical Cancer Prevention and Treatment Act of 2000. Atlanta: Centers for Disease Control and Prevention, 2003.
40. Smith R, Saslow D, Sawyer K, et al. American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003; 53:141-169.
41. U. S. Preventive Services Task Force Update, 2002 Release. Chemoprevention: Hormone Replacement. http://www.ahcpr.gov/clinic/uspstf/uspsmho.htm.